Inspire Medical Systems, Inc. (INSP) stock
INSPNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 17/3029% below fair value
$61.10+0.56 (+0.93%)
Close on Nov 13, 2026Market cap $1.77BP/E 17.8Yield –
Inspire Medical Systems operating margin
Operating margin is operating income as a percentage of revenue.
Inspire Medical Systems's operating margin for the twelve months ending Sep 30, 2026 was 1.8%. For fiscal 2025 it was 5.6%, against 4.5% the year before. The highest annual figure on record is 5.6% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5.6% | +1.1 |
| FY2024 | Dec 31, 2024 | 4.5% | +10.9 |
| FY2023 | Dec 31, 2023 | -6.4% | +5.2 |
| FY2022 | Dec 31, 2022 | -11.7% | +5.4 |
| FY2021 | Dec 31, 2021 | -17.1% | +31.6 |
| FY2020 | Dec 31, 2020 | -48.7% | −6.2 |
| FY2019 | Dec 31, 2019 | -42.5% | −2.3 |
| FY2018 | Dec 31, 2018 | -40.3% | +15.7 |
| FY2017 | Dec 31, 2017 | -56.0% | +49.0 |
| FY2016 | Dec 31, 2016 | -105.0% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -13.9% | −18.2 |
| Q2 FY2026 | Jun 30, 2026 | -0.3% | +1.3 |
| Q1 FY2026 | Mar 31, 2026 | -0.5% | +0.2 |
| Q4 FY2025 | Dec 31, 2025 | 17.1% | +3.8 |
| Q3 FY2025 | Sep 30, 2025 | 4.3% | −2.8 |
| Q2 FY2025 | Jun 30, 2025 | -1.5% | −4.1 |
| Q1 FY2025 | Mar 31, 2025 | -0.7% | +8.5 |
| Q4 FY2024 | Dec 31, 2024 | 13.3% | +8.5 |
| Q3 FY2024 | Sep 30, 2024 | 7.0% | +15.8 |
| Q2 FY2024 | Jun 30, 2024 | 2.6% | +13.6 |
| Q1 FY2024 | Mar 31, 2024 | -9.3% | +6.0 |
| Q4 FY2023 | Dec 31, 2023 | 4.8% | +5.1 |
| Q3 FY2023 | Sep 30, 2023 | -8.8% | +7.0 |
| Q2 FY2023 | Jun 30, 2023 | -11.0% | +4.3 |
| Q1 FY2023 | Mar 31, 2023 | -15.2% | +7.9 |
| Q4 FY2022 | Dec 31, 2022 | -0.2% | +2.1 |
| Q3 FY2022 | Sep 30, 2022 | -15.7% | +0.1 |
| Q2 FY2022 | Jun 30, 2022 | -15.3% | +8.4 |
| Q1 FY2022 | Mar 31, 2022 | -23.1% | +15.7 |
| Q4 FY2021 | Dec 31, 2021 | -2.3% | +13.0 |
| Q3 FY2021 | Sep 30, 2021 | -15.9% | +11.7 |
| Q2 FY2021 | Jun 30, 2021 | -23.7% | +163.6 |
| Q1 FY2021 | Mar 31, 2021 | -38.9% | +38.1 |
| Q4 FY2020 | Dec 31, 2020 | -15.3% | +19.2 |
| Q3 FY2020 | Sep 30, 2020 | -27.6% | +13.9 |
| Q2 FY2020 | Jun 30, 2020 | -187.3% | −141.9 |
| Q1 FY2020 | Mar 31, 2020 | -77.0% | −23.0 |
| Q4 FY2019 | Dec 31, 2019 | -34.5% | −5.0 |
| Q3 FY2019 | Sep 30, 2019 | -41.5% | −5.9 |
| Q2 FY2019 | Jun 30, 2019 | -45.3% | +6.2 |
| Q1 FY2019 | Mar 31, 2019 | -54.0% | −2.3 |
| Q4 FY2018 | Dec 31, 2018 | -29.6% | +9.1 |
| Q3 FY2018 | Sep 30, 2018 | -35.6% | +14.6 |
| Q2 FY2018 | Jun 30, 2018 | -51.5% | +21.0 |
| Q1 FY2018 | Mar 31, 2018 | -51.7% | +26.1 |
| Q4 FY2017 | Dec 31, 2017 | -38.6% | – |
| Q3 FY2017 | Sep 30, 2017 | -50.2% | – |
| Q2 FY2017 | Jun 30, 2017 | -72.6% | – |
| Q1 FY2017 | Mar 31, 2017 | -77.9% | – |
See a number that looks wrong?